Difference between revisions of "Calretinin"
Jump to navigation
Jump to search
| Line 9: | Line 9: | ||
*[[Sex cord-stromal tumours]]. | *[[Sex cord-stromal tumours]]. | ||
*[[Adrenal cortical carcinoma]]. | *[[Adrenal cortical carcinoma]]. | ||
*[[Colorectal carcinoma]] -ve/+ve<ref name=pmid8898855>{{Cite journal | last1 = Cargnello | first1 = R. | last2 = Celio | first2 = MR. | last3 = Schwaller | first3 = B. | last4 = Gotzos | first4 = V. | title = Change of calretinin expression in the human colon adenocarcinoma cell line HT29 after differentiation. | journal = Biochim Biophys Acta | volume = 1313 | issue = 3 | pages = 201-8 | month = Oct | year = 1996 | doi = | PMID = 8898855 }}</ref> - tend to be MSI-H. | |||
==Negative== | ==Negative== | ||
Revision as of 03:24, 21 March 2018
Calretinin is a common immunostain.
Positive
- Benign mesothelium, e.g. benign mesothelial inclusion cyst.[1]
- Adrenal.[citation needed]
Malignant/tumour
- Malignant mesothelioma.
- Sex cord-stromal tumours.
- Adrenal cortical carcinoma.
- Colorectal carcinoma -ve/+ve[2] - tend to be MSI-H.
Negative
See also
References
- ↑ Urbańczyk, K.; Skotniczny, K.; Kuciński, J.; Friediger, J. (2005). "Mesothelial inclusion cysts (so-called benign cystic mesothelioma)--a clinicopathological analysis of six cases.". Pol J Pathol 56 (2): 81-7. PMID 16092670.
- ↑ Cargnello, R.; Celio, MR.; Schwaller, B.; Gotzos, V. (Oct 1996). "Change of calretinin expression in the human colon adenocarcinoma cell line HT29 after differentiation.". Biochim Biophys Acta 1313 (3): 201-8. PMID 8898855.
- ↑ Sangoi, AR.; McKenney, JK. (Mar 2010). "A tissue microarray-based comparative analysis of novel and traditional immunohistochemical markers in the distinction between adrenal cortical lesions and pheochromocytoma.". Am J Surg Pathol 34 (3): 423-32. doi:10.1097/PAS.0b013e3181cfb506. PMID 20154585.